Michael McCullar, CEO and Hong Tang, Co-Founder and Chief Medical Officer OnQuality Pharmaceuticals describe the pipeline they are building to address unmet clinical needs in the area of oncology supportive care for skin rashes such as Hand-Foot Skin Reaction and GI toxicities like chemotherapy-induced diarrhea. As leaders in the emerging oncodermatology and oncogastroenterology fields, the mission is to develop cancer supportive care drugs to deal with the most common toxicities to make it easier for patients to tolerate their cancer treatments.
@OnQualityRx #cancer #cancertherapy #cancerresearch #chemotherapy #supportivecare #cancertherapeutics #pharma
OnQualityRx.com
Download the transcript here
Empowered Patient Podcast